Julian Beach, MHRA Interim Executive Director, Healthcare Quality and Access, said: “As the first new type of oral antibiotic ...

One innovative approach that has gained traction in recent years is gamification—the integration of game elements such as ...

Zack Lentz has been appointed as Chief Commercial Officer at OPEN Health, a company with a global focus on medical affairs, ...

Sanofi has appointed Lisa Sha as general manager, vaccines, for the UK and Ireland. She takes up the role with immediate ...

ReAlta Life Sciences has received orphan drug designation from the European Medicines Agency (EMA) for its investigational therapy RLS-0071 (pegtarazimod) in graft-versus-host disease (GvHD). The ...

Pfizer and BioNTech’s supplemental Biologics License Application (sBLA) has been approved by the US Food and Drug ...

Eli Lilly has shared positive top-line results from a late-stage study of its investigational oral glucagon-like peptide-1 ...

The alliance, originally announced in November 2023, combines Almirall’s dermatological capabilities with Absci’s Integrated ...

The UK government has published its 10-Year Health Plan for England, which will see millions of patients being treated and ...

Eli Lilly has announced that its new therapeutic Verzenio (abemaciclib), given alongside standard endocrine therapy, improves overall survival in people with high-risk, early-stage breast cancer that ...

Boehringer Ingelheim’s Hernexeos (zongertinib) has been granted accelerated approval by the US Food and Drug Administration ...

Jason Reese has been appointed as VML Health’s Global chief transformation officer, as the company continues to focus on ...